Every week neurologist Victor Sung sees people with Huntington’s disease, a rare and devastating neurodegenerative disorder, at his clinic at the University of Alabama at Birmingham. But last ...

Readers respond to a guest essay by Keith Humphreys and an article about a fentanyl death. To the Editor: Re “Forced Drug Treatment Isn’t Horrific. It’s a Relief,” by Keith Humphreys (Opinion guest ...

President Donald Trump and his top health aides plan to link a common over-the-counter pain medication to autism and name another drug as a possible treatment for the brain development condition.

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Nick Benz-Bushling never imagined that managing his son’s mental health care would turn into a real-life horror story. After years of struggles, 16-year-old Johnathan attempted suicide in February.

EAST RUTHERFORD, N.J. -- New York Giants co-owner John Mara revealed Monday that he was recently diagnosed with cancer. Mara, who serves as the team's president and CEO, was at the team's 21-18 win ...

Australia has become the 50th country to register the drug lecanemab (LEQEMBI) following a clinical trial, and is a major development to provide eligible patients with a new treatment. The drug helps ...

People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...

A gamer seeking financial support for cancer treatment lost $32,000 after downloading from Steam a verified game named BlockBlasters that drained his cryptocurrency wallet. BlockBlasters is a 2D ...

Leucovorin has now got FDA nod for treating cerebral folate deficiency, a neurological condition, that can lead to low levels of vitamin B9 (folate) levels in the brain. The Food and Drug ...